ClinicalTrials.gov
public full text
Public Domain
Sub-dissociative Dose Ketamine in Treatment of Vaso-occlusive Pain Event in Children and Young Adults
The purpose of this research is to see if ketamine is effective and safe in treating children and young adults with sickle cell disease experiencing sickle cell related pain. In this study, we will compare the outcomes (such as pain scores) in persons who receive standard of care pain medicine (an opioid such as morphine) plus a low dose (amount) of ketamine to those who receive only standard of care pain medicine.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Survey of Knowledge and Attitude of Pain in Anesthesia Residents of Thailand#1198255
- EEG Studies of Sevoflurane-Induced General Anesthesia#854187
- Pain Prevalence in Hospitalized Patients#856548
- Effectiveness of Electrical Neurostimulation in Cyclic Vomiting Syndrome.#864522
- Effect of Mulligan Mobilization With or Without Niel Asher Technique in Patients With Adhesive Capsulitis#882702
Record · ID 1196646
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive